Valvular & structural heart disease
Rheumatic Heart Disease Burden: A Comparative Analysis between the United States and the European Union
Authors' conclusion
The varied trends underscore the complexity of RHD epidemiology
Study context
- Population
- Rheumatic heart disease burden in the United States of America (USA) and the European Union (EU), 1993–2021
- Exposure
- USA vs EU
- Outcome
- RHD age-standardized prevalence (ASPR) and incidence (ASIR)
- Follow-up
- 2021
Methodological detailsGlobal Burden of Disease Study 2021 data, Age-standardized rates and estimated annual percentage change (EAPC) from the Global Health Data Exchange query tool
- Global Burden of Disease Study 2021 data
- Age-standardized rates and EAPC from the Global Health Data Exchange query tool
Main finding
As reported in the abstract
| Group | ASPR 2021 | ASPR annual trend since 1993 | ASIR 1993 to 2021 | ASPR annual trend 1993–2021 |
|---|---|---|---|---|
| USA | 123.4/100,000 | decreasing 0.32% | 10.6 to 10.0/100,000 | |
| EU | 49.7/100,000 | 7.43 to 4.6/100,000 | decreasing 1.6% |
ASPR 2021
USA123.4/100,000
EU49.7/100,000
ASPR annual trend since 1993
USAdecreasing 0.32%
EU— not stated in the abstract
ASIR 1993 to 2021
USA10.6 to 10.0/100,000
EU7.43 to 4.6/100,000
ASPR annual trend 1993–2021
USA— not stated in the abstract
EUdecreasing 1.6%
Observational data: associations, not effects.
Further findings
Drivers of US prevalence and incidence change
- Primarily driven by Florida, Nevada and Tennessee
- Reversal in rheumatic heart disease (RHD) burden in the USA since 2007
Sex disparity
- Significant gender disparity with female predominance in both regions
Age-standardized DALYs and YLLs
- Higher in the EU than the USA
Original publication
Rheumatic Heart Disease Burden: A Comparative Analysis between the United States and the European Union. JACC Adv. Published 11 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →